| CD133+ liver tumor‐initiating cells promote tumor angiogenesis, growth, and self‐renewal through neurotensin/interleukin‐8/CXCL1 signaling KH Tang, S Ma, TK Lee, YP Chan, PS Kwan, CM Tong, IO Ng, K Man, ... Hepatology 55 (3), 807-820, 2012 | 310 | 2012 |
| Blockade of CD47‐mediated cathepsin S/protease‐activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma TKW Lee, VCH Cheung, P Lu, EYT Lau, S Ma, KH Tang, M Tong, J Lo, ... Hepatology 60 (1), 179-191, 2014 | 214 | 2014 |
| Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells S Chai, KY Ng, M Tong, EY Lau, TK Lee, KW Chan, YF Yuan, TT Cheung, ... Hepatology 64 (6), 2062-2076, 2016 | 207 | 2016 |
| A CD90+ tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer KH Tang, YD Dai, M Tong, YP Chan, PS Kwan, L Fu, YR Qin, SW Tsao, ... Cancer research 73 (7), 2322-2332, 2013 | 188 | 2013 |
| EPHB2 activates β-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma HW Leung, CON Leung, EY Lau, KPS Chung, EH Mok, MML Lei, ... Cancer Research 81 (12), 3229-3240, 2021 | 148 | 2021 |
| Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma M Tong, KW Chan, JYJ Bao, KY Wong, JN Chen, PS Kwan, KH Tang, ... Cancer research 72 (22), 6024-6035, 2012 | 140 | 2012 |
| Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib M Tong, N Che, L Zhou, ST Luk, PW Kau, S Chai, ES Ngan, CM Lo, ... Journal of hepatology 69 (4), 826-839, 2018 | 121 | 2018 |
| ANXA3/JNK signaling promotes self-renewal and tumor growth, and its blockade provides a therapeutic target for hepatocellular carcinoma M Tong, TM Fung, ST Luk, KY Ng, TK Lee, CH Lin, JW Yam, KW Chan, ... Stem cell reports 5 (1), 45-59, 2015 | 107 | 2015 |
| Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma S Ma, JYJ Bao, PS Kwan, YP Chan, CM Tong, L Fu, N Zhang, AHY Tong, ... Gastroenterology 143 (3), 675-686. e12, 2012 | 105 | 2012 |
| Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma EHK Mok, CON Leung, L Zhou, MML Lei, HW Leung, M Tong, TL Wong, ... Cancer Research 82 (17), 3102-3115, 2022 | 97 | 2022 |
| Glucose deprivation–induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma JHC Loong, TL Wong, M Tong, R Sharma, L Zhou, KY Ng, HJ Yu, CH Li, ... The Journal of Clinical Investigation 131 (11), 2021 | 97 | 2021 |
| Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma CON Leung, M Tong, KPS Chung, L Zhou, N Che, KH Tang, J Ding, ... Hepatology 72 (1), 155-168, 2020 | 88* | 2020 |
| ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer TL Wong, JJ Loh, S Lu, HHN Yan, HC Siu, R Xi, D Chan, MJF Kam, ... Nature Communications 14 (1), 2861, 2023 | 86 | 2023 |
| FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness JJ Loh, TW Li, L Zhou, TL Wong, X Liu, VWS Ma, CM Lo, K Man, TK Lee, ... Cancer Research 81 (22), 5692-5705, 2021 | 86 | 2021 |
| Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133 S Chai, M Tong, KY Ng, PS Kwan, YP Chan, TM Fung, TK Lee, N Wong, ... Oncotarget 5 (14), 5725, 2014 | 84 | 2014 |
| Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells QZ Pan, K Pan, QJ Wang, DS Weng, JJ Zhao, HX Zheng, XF Zhang, ... Stem cells 33 (2), 354-366, 2015 | 82 | 2015 |
| FSTL1 promotes metastasis and Chemoresistance in esophageal squamous cell carcinoma through NFκB–BMP signaling cross-talk MCC Lau, KY Ng, TL Wong, M Tong, TK Lee, XY Ming, S Law, NP Lee, ... Cancer research 77 (21), 5886-5899, 2017 | 75 | 2017 |
| C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties KY Ng, S Chai, M Tong, XY Guan, CH Lin, YP Ching, D Xie, ASL Cheng, ... Oncotarget 7 (17), 24005, 2016 | 75 | 2016 |
| Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression L Zhou, HO Ken, TL Wong, Z Zhang, CH Chan, JHC Loong, N Che, HJ Yu, ... Gut 71 (8), 1656-1668, 2022 | 74 | 2022 |
| Biology of hepatic cancer stem cells CM Tong, S Ma, XY Guan Journal of gastroenterology and hepatology 26 (8), 1229-1237, 2011 | 73 | 2011 |
Stephanie MaThe University of Hong KongVerified email at hku.hk
